Catherine Lubetzki is professor of Neurology at Sorbonne University, head of the university department of Neuroscience and coordinator of the MS center in Pitié-Salpêtrière Hospital, Paris, France.
She is or has been involved in several committees and funding boards : member of ECTRIMS (European congress on multiple sclerosis) executive committee, past-president of the scientific committee of ARSEP (French multiple sclerosis association for research), member of International Progressive MS Alliance Scientific Steering Committee. She is elected chair for the next Gordon Research Conference in myelin. She acts as vice president of Sorbonne University Foundation.
Her clinical activity is mainly dedicated to the management of patients with multiple sclerosis and other inflammatory central nervous system diseases, combining care with a very active clinical research.
She leads, together with Pr Bruno Stankoff, a research group in the Paris Brain Institute (ICM) within the Salpetriere campus. The general aim of this translational research team is to develop strategies to prevent neurodegeneration and reduce disability progression in Multiple Sclerosis patients, by combining basic sciences of neuroglial cells, identification of pro-myelinating candidates and imaging of myelin loss and repair.